Arkolith/Insider Trading/MEIP/Form 4

Urso David M

Chief Operating Officer & GCMEI Pharma, Inc. (MEIP) · full profile →Form 4 · filed Jul 6, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 2, 2021Tax withholding(F)25K$2.94$73K49K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 1, 2021Grant(A)600K—$0600K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-045640) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML